Cargando…
Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy
Evidence for research over the past decade shows that epigenetic regulation mechanisms run through the development and prognosis of tumors. Therefore, small molecular compounds targeting epigenetic regulation have become a research hotspot in the development of cancer therapeutic drugs. According to...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686570/ https://www.ncbi.nlm.nih.gov/pubmed/33262941 http://dx.doi.org/10.3389/fonc.2020.560487 |